Cite
Toward the harmonization of immune monitoring in clinical trials: Quo vadis?
MLA
Britten, C. M., et al. “Toward the Harmonization of Immune Monitoring in Clinical Trials: Quo Vadis?” Cancer Immunology, Immunotherapy, vol. 57, no. 3, Mar. 2008, pp. 285–88. EBSCOhost, https://doi.org/10.1007/s00262-007-0379-z.
APA
Britten, C. M., Janetzki, S., van der Burg, S. H., Gouttefangeas, C., & Hoos, A. (2008). Toward the harmonization of immune monitoring in clinical trials: Quo vadis? Cancer Immunology, Immunotherapy, 57(3), 285–288. https://doi.org/10.1007/s00262-007-0379-z
Chicago
Britten, C. M., S. Janetzki, S. H van der Burg, C. Gouttefangeas, and A. Hoos. 2008. “Toward the Harmonization of Immune Monitoring in Clinical Trials: Quo Vadis?” Cancer Immunology, Immunotherapy 57 (3): 285–88. doi:10.1007/s00262-007-0379-z.